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Total Occlusion Recanalization*
Wissam Jaber, MD, Habib Samady, MDSEE PAGE 1G iven its historically low procedural successrate, chronic total occlusion (CTO) percuta-neous coronary intervention (PCI) has long
been considered the Achilles’ heel of percutaneous
revascularization. Recent years, however, have wit-
nessed signiﬁcant progress in the ﬁeld. Indeed, the
adoption of novel strategies coupled with dedication
and perseverance of pioneering operators has
increased CTO PCI success rates in expert hands
from 50% to 90% (1). Techniques that expanded
recanalization options, including antegrade and
retrograde subintimal tracking, that were originally
mastered by Japanese interventionalists have been
adopted and streamlined in North America.
Despite these advances, PCI continues to be an un-
derused treatment option for CTO lesions (1). There are
3 main reasons for this. First, the indications for CTO
PCI remain controversial. On the one hand is the
argument that a total occlusion (particularly with col-
laterals) is a relatively stable situation, whereas on the
other hand, observational data suggest that patients
with nonrevascularized CTOs have worse outcome
than those with non-CTO disease or with revascular-
ized CTOs, possibly due to the “double jeopardy” of
territory if the collateral donor vessel develops an oc-
clusion (2). Presently, CTO PCI carries a lower Appro-
priate Use Criteria score than non-CTO PCI for similar
clinical and angiographic scenarios (3). The second
reason for the underuse of CTO PCI relates to concerns
about procedural and radiation safety, and increased
resource utilization. The third reason is the low pro-
cedural success rates among non-expert CTOoperators*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
From the Division of Cardiology, Department of Medicine, Emory
University School of Medicine, Atlanta, Georgia. Both authors have re-
ported that they have no relationships relevant to the contents of this
paper to disclose.and the inability to predict procedural success. As with
any new and complex procedure, high success rates
require extensive training, advanced skillsets, and a
high procedural volume. These reasons have limited
the wide applicability and dissemination of advanced
techniques to the larger general interventional com-
munity. A simple clinical and angiographic score to
predict procedural success would allow operators to
quickly assess the risk–beneﬁt ratio of CTO PCI.PROGRESS CTO is a prospective registry of CTO PCI
performed at limited high volume expert CTO centers
across the United States. In this current issue of JACC:
Cardiovascular Interventions, Christopoulous et al. (4)
report data from the PROGRESS CTO (Prospective
Global Registry for the Study of Chronic Total Occlu-
sion Intervention) registry and attempt to identify a
scoring system that can predict success of PCI. They
included 762 real-world patients, 35%ofwhomhadhad
prior bypass surgery and 66%, prior PCI. Procedural
success rate was 93%.Multivariable analysis identiﬁed
4 factors that were independently associated with
failure to achieve technical success: proximal cap am-
biguity, lack of interventional collaterals, tortuosity,
and attempting a left circumﬂex CTO. Each factor was
assigned 1 point, with the PROGRESS score represent-
ing the total number of points. The PROGRESS score
was derived from two-thirds of the cohort and vali-
dated on the remaining third. It was moderately pre-
dictive of a successful procedure with a derivation c
value of 0.78 and the validation c value of 0.72.
Thus far, the Multicenter CTO Registry of Japan
(J-CTO) score had provided clinicians with a lesion
complexity score and likelihood of successfully
wiring the lesion within 30 min (5). The J-CTO score is
the sum of 5 predictors of failure: blunt proximal cap,
excessive tortuosity, long occlusion (>20 mm), pres-
ence of calciﬁcation in the CTO segment, and prior
failed PCI attempt.
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11Does the PROGRESS score offer an improvement
over the J-CTO score? Will it replace the J-CTO score in
the modern practice? The new PROGRESS score has
the following advantages: 1) it includes only 4 vari-
ables instead of the 5 variables in J-CTO; 2) 1 of the
variables of the J-CTO score, a prior unsuccessful PCI,
can be unreliable as it depends on the experience of
the prior operator; and 3) unlike the J-CTO score, the
PROGRESS score is derived from and applies to the
more contemporary hybrid CTO PCI approach. The
hybrid approach proposes a procedural algorithm
based on the proximal cap of the CTO, the distal vessel
quality and the suitability of collateral vessels,
allowing the operator to start with either an antegrade
or retrograde crossing strategy and rapidly switch
back and forth between the 2 strategies in the same
setting as needed (6). Potential limitations of the
PROGRESS score include the deﬁnition of “absence of
interventional collaterals,” which can be subjective
and dependent on operator experience, and the low
number of failed procedures in the derivation cohort.
The authors should be commended for comparing
the predictive accuracy of the J-CTO score to the
PROGRESS score. They found that overall the J-CTO
score performed similarly to the PROGRESS score,
with perhaps even better accuracy for predicting
procedural success at lower scores. An important
feature of the J-CTO score, which is quite simple and
widely used, is its prognostic value (7). It will be
interesting to evaluate the prognostic value of the
PROGRESS score with respect to outcomes, particu-
larly that variables such as circumﬂex location of the
CTO or absence of interventional collaterals may not
portend adverse prognosis per se.
Although we suspect that the new PROGRESS-CTO
score will be commonly used in clinical practice, the
J-CTO score will continue to be an important tool in
assessing lesion complexity and predicting outcomes.However, both scores have been derived from regis-
tries collected from high-volume and experienced
operators. To what extent the scores apply to the
general interventional community is not clear.
External validation in a larger CTO registry is
warranted.
The authors should be congratulated for their efforts
in creating and maintaining the PROGRESS CTO regis-
try. Given the complexities of designing a large ran-
domized controlled trial, such registry data shed
important light on the state of the ﬁeld and inform
clinical care. The PROGRESS and J-CTO scores, by
predicting procedural success, can help physicians and
patients set PCI expectations in the context of alter-
native options such as medical therapy, bypass sur-
gery, and enhanced external counter-pulsation
therapy. Innovation in pharmacotherapy, cell therapy,
and transvenous coronary sinus reducer technology
among others will add to traditional revascularization
options for treatment of angina and ischemia.
Given the prolonged learning curve and resources
required in performing CTO PCI, such procedures
should continue to be performed by highly trained
operators at tertiary care centers. Dedicated CTO PCI
registries would continue to improve our under-
standing of the procedure and track quality metrics
including appropriate indication, procedural success
rates, complication rates, radiation dose, and contrast
volume, as well as cost. Ongoing efforts to improve
CTO PCI techniques and lessons learned from regis-
tries such as PROGRESS CTO will guide clinicians to
provide the best options to our patients.
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